UNSPSC 51442500: Manganese-based radiopharmaceuticals, imaging agents, media, and tracers

This classification denotes particle- or wave-sensitive substances that practitioners use in to enhance visualization of bodily fluids, structures, and/or tissue, or otherwise, as biological indicators in diagnosis of disease, substances that are commonly called agents, media, or tracers, and which are also compounds based in part or whole on manganese, which practitioners use chiefly in Magnetic Resonance Imaging (MRI) and/or Magnetic Resonance Spectroscopy (MRS), thus the term MANGANESE-BASED RADIOPHARMACEUTICALS, IMAGING AGENTS, MEDIA, AND TRACERS.

UNSPSC 51442500 Manganese-based radiopharmaceuticals, imaging agents, media, and tracers is a Class code that shows little relevant recent state and local procurement activity. The four opportunities posted between June and October 2026 under this code involve radiologic and X-ray equipment procurement, extended equipment warranties, maintenance service plans for X-ray inspection systems, and chemical supplies — none of which align with the code's nominal scope of manganese-based radiopharmaceuticals or imaging tracers. State and local procurement systems appear to have tagged these opportunities with a code that does not reflect the work being solicited.

The mismatch between code designation and actual procurement scope makes this code unsuitable for pursuing as a radiopharmaceutical or medical imaging agent channel. Business development professionals should verify whether manganese-based radiopharmaceutical opportunities are classified under a different UNSPSC code or whether state and local governments in your target markets use this code inconsistently. The absence of authentic manganese-radiopharmaceutical solicitations in the recent record suggests either no current demand for this commodity type in state and local markets or systematic miscoding of related opportunities.